Defang Ouyang

6.1k total citations · 2 hit papers
142 papers, 4.4k citations indexed

About

Defang Ouyang is a scholar working on Pharmaceutical Science, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Defang Ouyang has authored 142 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pharmaceutical Science, 45 papers in Molecular Biology and 32 papers in Materials Chemistry. Recurrent topics in Defang Ouyang's work include Drug Solubulity and Delivery Systems (43 papers), Analytical Chemistry and Chromatography (29 papers) and Computational Drug Discovery Methods (27 papers). Defang Ouyang is often cited by papers focused on Drug Solubulity and Delivery Systems (43 papers), Analytical Chemistry and Chromatography (29 papers) and Computational Drug Discovery Methods (27 papers). Defang Ouyang collaborates with scholars based in Macao, China and United Kingdom. Defang Ouyang's co-authors include Zhuyifan Ye, Jie Dong, Dongsheng Cao, Hanlu Gao, Ningning Wang, Aiping Lü, Wei Wang, Lin Zhang, Zhi‐Jiang Yao and Cheng Yan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Defang Ouyang

135 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database

2018 591 citations Jie Dong, Defang Ouyang et al. profile →
Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery

2024 70 citations Yi‐Yang Wu, Defang Ouyang et al. profile →

Peers

Countries citing papers authored by Defang Ouyang

Since Specialization

Citations

This map shows the geographic impact of Defang Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defang Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defang Ouyang more than expected).

Fields of papers citing papers by Defang Ouyang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Defang Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Defang Ouyang. The network helps show where Defang Ouyang may publish in the future.

Co-authorship network of co-authors of Defang Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Defang Ouyang. A scholar is included among the top collaborators of Defang Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Defang Ouyang. Defang Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine learning-driven insights into retention mechanism in IAM chromatography of anticancer sulfonamides: Implications for biological efficacy 2025 ·Journal of Chromatography A ·(unknown), Beata Żołnowska, (unknown), (unknown), (unknown), Katarzyna Ewa Greber, Aneta Pogorzelska, (unknown), (unknown), (unknown), Anna Kawiak, Wiesław Sawicki, Defang Ouyang, Jarosław Sławiński, Krzesimir Ciura	0
2	Inhalable Artificial Polymeric Nucleases Degrading Neutrophil Extracellular Trap‐DNAs and Alleviating Pulmonary Fibrosis 2025 ·Advanced Science ·(unknown), (unknown), (unknown), Shi Chen, (unknown), Defang Ouyang, Lixin Liu, Yongming Chen	1
3	Artificial intelligence for drug delivery: Yesterday, today and tomorrow 2025 ·Acta Pharmaceutica Sinica B ·(unknown), Nannan Wang, Ping Xiong, (unknown), (unknown), Defang Ouyang	3
4	In silico prediction of metabolic stability for ester-containing molecules: Machine learning and quantum mechanical methods 2024 ·Chemometrics and Intelligent Laboratory Systems ·Shiwei Deng, Yi‐Yang Wu, Zhuyifan Ye, Defang Ouyang	2
5	Introducing enzymatic cleavage features and transfer learning realizes accurate peptide half-life prediction across species and organs 2024 ·Briefings in Bioinformatics ·Xiaorong Tan, Qianhui Liu, (unknown), Sen Yang, Fei Chen, Jianmin Wang, Defang Ouyang, Jie Dong, Wenbin Zeng	8
6	Predicting Peptide Permeability Across Diverse Barriers: A Systematic Investigation 2024 ·Molecular Pharmaceutics ·Xiaorong Tan, (unknown), (unknown), Yingli Zhu, Fei Chen, Wenbin Zeng, Defang Ouyang, Jie Dong	8
7	Perylenedioic Acid‐Derived Carbon Dots with Near 100% Quantum Yield in Aqueous Solution for Lasing and Lighting 2024 ·Advanced Functional Materials ·Yupeng Liu, Bingzhe Wang, Yunsen Zhang, Jia Guo, Xiaoyi Wu, Defang Ouyang, Shi Chen, Yeqing Chen, Shuangpeng Wang, Guichuan Xing, Zikang Tang, Songnan Qu	58
8	Dynamic immuno-nanomedicines in oncology 2023 ·Journal of Controlled Release ·Hao Ling, Qinyi Zhang, Qiuhua Luo, Defang Ouyang, Zhonggui He, (unknown), Mengchi Sun	0
9	Erythrocyte‐Leveraged Oncolytic Virotherapy (ELeOVt): Oncolytic Virus Assembly on Erythrocyte Surface to Combat Pulmonary Metastasis and Alleviate Side Effects 2023 ·Advanced Science ·Mingyang Liu, Ruizhe Zhang, Hanwei Huang, Pengfei Liu, (unknown), Hu Wu, (unknown), (unknown), (unknown), Zhenguo Cheng, Hongyu Liu, Önder Ergönül, Füsun Can, Defang Ouyang, Zhenning Wang, Zhiqing Pang, Funan Liu	13
10	An oral bacterial pyroptosis amplifier against malignant colon cancer 2023 ·Nano Today ·Xinyu Lou, Jinqiang Wang, (unknown), Xu Wang, (unknown), Dongchun Liu, Xianbao Shi, Defang Ouyang, Zhonggui He, Jin Sun, Hongjun Li, Mengchi Sun	13
11	Molecular Dynamics Simulation of Drug Solubilization Behavior in Surfactant and Cosolvent Injections 2022 ·Pharmaceutics ·(unknown), Wenwen Zheng, Nannan Wang, Hanlu Gao, Defang Ouyang, Zunnan Huang	25
12	Tumor microenvironment adrenergic nerves blockade liposomes for cancer therapy 2022 ·Journal of Controlled Release ·Shuang Zhou, Jinbo Li, Yu Jiang, Yuequan Wang, Zhaomeng Wang, Zhonggui He, Defang Ouyang, (unknown), Yongjun Wang	14
13	Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies 2020 ·International Journal of Molecular Sciences ·Xiaowen Zhang, Jiayue Chen, Defang Ouyang, Jiahong Lu	86
14	The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review 2020 ·Phytomedicine ·Shuang Zhang, Qi Zhu, Jiayue Chen, Defang Ouyang, Jiahong Lu	56
15	PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation 2020 ·Autophagy ·Mingyue Wu, Le Liu, (unknown), Haitao Xiao, Cui-Zan Cai, Jing Wang, Huanxing Su, Yitao Wang, Jieqiong Tan, Zhuohua Zhang, Juan Wang, (unknown), Defang Ouyang, Zhenyu Yue, Min Li, Ye Chen, Zhaoxiang Bian, Jiahong Lu	65
16	Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions 2018 ·Chinese Medicine ·(unknown), Ging Chan, Hu Y, Defang Ouyang, Carolina Oi Lam Ung, (unknown), Hao Hu	125
17	A Comprehensive Map of FDA-Approved Pharmaceutical Products 2018 ·Pharmaceutics ·Hao Zhong, Ging Chan, Hu Y, Hao Hu, Defang Ouyang	219
18	Predicting oral disintegrating tablet formulations by neural network techniques 2018 ·Asian Journal of Pharmaceutical Sciences ·Run Han, Yilong Yang, Xiaoshan Li, Defang Ouyang	67
19	Computer-Aided Formulation Design for a Highly Soluble Lutein–Cyclodextrin Multiple-Component Delivery System 2018 ·Molecular Pharmaceutics ·Qianqian Zhao, (unknown), Yan Su, Weijie Chen, Xuejiao Gao, (unknown), Ru Yan, Haifeng Li, Xiaojun Yao, Dongsheng Cao, Yitao Wang, Defang Ouyang	52
20	Molecular Encapsulation of Histamine H2-Receptor Antagonists by Cucurbit[7]Uril: An Experimental and Computational Study 2016 ·Molecules ·Hang Yin, (unknown), (unknown), Jian‐Bo Wan, Ying Zheng, Defang Ouyang, Ruibing Wang	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact